Revolution Medicines, Inc. is 3.7x more valuable than HALOZYME THERAPEUTICS, INC. by market capitalization ($30.74 B vs $8.36 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HALO | RVMD |
|---|---|---|
| Market cap | $8.36 B | $30.74 B |
| US-listed rank | #1040 | #453 |
| Revenue (latest FY) | $1.40B | $0.00 |
| Net income (latest FY) | $316.89M | -$1.13B |
| Net margin | 22.7% | - |
| P/E (trailing FY) | 26.4 | - |
| SEC filings | 1,481 | 782 |
Revolution Medicines, Inc. is 3.7x more valuable than HALOZYME THERAPEUTICS, INC. by market capitalization ($30.74 B vs $8.36 B).
In their latest fiscal years, HALOZYME THERAPEUTICS, INC. reported $1.40B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: HALOZYME THERAPEUTICS, INC. and Revolution Medicines, Inc., or browse the full rankings.